Key Leadership Changes
Perrigo Company plc, a leading provider of over-the-counter (OTC) health products, has announced a leadership transition. Patrick Lockwood-Taylor has resigned as President and CEO and from the Board of Directors. Albert A. Manzone has been appointed as Interim President and CEO, also joining the Board.
Who is Albert A. Manzone?
Albert A. Manzone brings extensive experience in the pharmaceutical and consumer goods sectors. He previously served as CEO of Bausch Health Companies, Prestige Brands, and Chattem. His expertise includes brand management, operational efficiency, and corporate strategy. The Perrigo Board expressed confidence in his ability to ensure continuity and stability during the transition.
Reasons for Resignation and Future Plans
The reasons for Patrick Lockwood-Taylor's resignation have not been disclosed. The company has begun a search for a permanent CEO, with Manzone overseeing the process alongside the Board. Perrigo continues to execute its strategy focused on strengthening its position in the OTC market.
FAQ
Why did the previous CEO leave?
Official reasons have not been provided. The company thanked him for his contributions and wished him well.
How will this affect Perrigo's business?
The leadership change is not expected to disrupt current operations. The appointment of an experienced interim CEO should ensure stability.
When will a permanent CEO be appointed?
No timeline has been announced. The search includes both internal and external candidates.
A virtual card in 2 minutes
Pay for subscriptions, AI tools, travel, and international stores. Top up via USDT-TRC20 with no acquiring fees.
